Barclays PLC Codexis, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Codexis, Inc. stock. As of the latest transaction made, Barclays PLC holds 207,628 shares of CDXS stock, worth $815,978. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,628

Previous 137,373 51.14%

Holding current value

$815,978

Previous $426,000 50.23%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$2.62 - $3.71 $184,068 - $260,646	70,255 Added 51.14%	207,628 $640,000
Q2 2024 Aug 14, 2024	SELL	$2.65 - $3.92 $72,087 - $106,635	-27,203 Reduced 16.53%	137,373 $426,000
Q1 2024 May 15, 2024	SELL	$2.59 - $4.65 $131,704 - $236,457	-50,851 Reduced 23.6%	164,576 $575,000
Q4 2023 Feb 15, 2024	BUY	$1.54 - $3.37 $92,972 - $203,453	60,372 Added 38.94%	215,427 $657,000
Q3 2023 Nov 07, 2023	BUY	$1.5 - $3.75 $168,433 - $421,083	112,289 Added 262.57%	155,055 $294,000
Q2 2023 Aug 03, 2023	SELL	$2.21 - $4.43 $39,097 - $78,371	-17,691 Reduced 29.26%	42,766 $120,000
Q1 2023 May 04, 2023	BUY	$3.81 - $6.76 $89,401 - $158,623	23,465 Added 63.43%	60,457 $250,000
Q4 2022 Feb 13, 2023	BUY	$4.26 - $6.84 $36,648 - $58,844	8,603 Added 30.3%	36,992 $173,000
Q3 2022 Nov 03, 2022	BUY	$6.06 - $12.86 $45,813 - $97,221	7,560 Added 36.3%	28,389 $172,000
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $70,114 - $183,810	-8,397 Reduced 28.73%	20,829 $218,000
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $805,531 - $1.52 Million	-47,468 Reduced 61.89%	29,226 $604,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $535,556 - $873,703	20,912 Added 37.49%	76,694 $2.4 Million
Q3 2021 Nov 09, 2021	BUY	$19.65 - $27.99 $663,403 - $944,970	33,761 Added 153.31%	55,782 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$17.48 - $25.46 $745,696 - $1.09 Million	-42,660 Reduced 65.95%	22,021 $499,000
Q1 2021 May 13, 2021	BUY	$18.08 - $28.8 $817,559 - $1.3 Million	45,219 Added 232.35%	64,681 $1.48 Million
Q4 2020 Feb 11, 2021	SELL	$11.7 - $23.41 $60,114 - $120,280	-5,138 Reduced 20.89%	19,462 $425,000
Q3 2020 Nov 12, 2020	SELL	$11.21 - $13.82 $54,839 - $67,607	-4,892 Reduced 16.59%	24,600 $289,000
Q2 2020 Aug 12, 2020	BUY	$9.8 - $12.77 $116,874 - $152,295	11,926 Added 67.89%	29,492 $336,000
Q1 2020 May 13, 2020	SELL	$8.78 - $18.6 $698,984 - $1.48 Million	-79,611 Reduced 81.92%	17,566 $196,000
Q4 2019 Feb 10, 2020	BUY	$13.12 - $17.06 $932,608 - $1.21 Million	71,083 Added 272.41%	97,177 $1.55 Million
Q3 2019 Nov 14, 2019	SELL	$12.75 - $19.01 $406,508 - $606,095	-31,883 Reduced 54.99%	26,094 $357,000
Q2 2019 Aug 14, 2019	BUY	$17.0 - $21.88 $202,147 - $260,175	11,891 Added 25.8%	57,977 $1.07 Million
Q1 2019 May 15, 2019	BUY	$15.53 - $22.15 $641,404 - $914,817	41,301 Added 863.13%	46,086 $946,000
Q4 2018 Feb 14, 2019	SELL	$14.06 - $22.57 $404,703 - $649,654	-28,784 Reduced 85.75%	4,785 $80,000
Q3 2018 Nov 14, 2018	BUY	$13.35 - $19.1 $377,991 - $540,797	28,314 Added 538.8%	33,569 $575,000
Q2 2018 Aug 14, 2018	SELL	$10.35 - $16.45 $37,767 - $60,026	-3,649 Reduced 40.98%	5,255 $75,000
Q1 2018 May 15, 2018	BUY	$8.0 - $12.8 $19,472 - $31,155	2,434 Added 37.62%	8,904 $98,000
Q4 2017 Feb 14, 2018	BUY	$5.85 - $8.4 $32,315 - $46,401	5,524 Added 583.93%	6,470 $54,000
Q3 2017 Nov 14, 2017	BUY	$4.9 - $6.65 $4,635 - $6,290	946	946 $6,000

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $257M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account